UBS Group AG - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$0
-100.0%
142
-97.3%
0.00%
Q2 2019$4,000
+300.0%
5,310
+440.2%
0.00%
Q1 2019$1,000
-90.9%
983
-81.8%
0.00%
Q3 2018$11,000
-80.0%
5,406
+1.5%
0.00%
Q2 2018$55,000
+450.0%
5,324
+243.7%
0.00%
Q1 2018$10,000
-66.7%
1,549
-59.9%
0.00%
Q4 2017$30,000
-11.8%
3,859
+9.7%
0.00%
Q3 2017$34,000
+70.0%
3,519
+127.2%
0.00%
Q2 2017$20,000
+17.6%
1,549
-29.0%
0.00%
Q4 2016$17,000
-5.6%
2,182
+33.7%
0.00%
Q3 2016$18,0001,6320.00%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders